Coverage
-
November 09, 2021
Attorneys from three firms asked a Massachusetts federal judge Monday for fees and costs totaling more than $1.8 million — or about 61% — of a nearly $3 million settlement to be paid by Takeda Pharmaceutical unit Shire and fellow drugmaker Actavis to resolve an antitrust suit.
9 other articles on this case.
View all »